适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Itb-Med AB
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
A study to investigate safety and efficacy with SAR445514 in participants with relapsed/refractory multiple myeloma (RRMM) and relapsed/refractory light-chain amyloidosis (RRLCA)CTIS2022-502057-33-00Sanofi-Aventis Recherche & Developpement105
招募中
1 期
A Phase 1, First-in-Human, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects with Advanced Solid TumorsCTIS2022-500849-24-00Tolremo Therapeutics AG25
招募中
1 期
Testing for the first time the effects of a new medicine in healthy peoplePsychatric disorderCTIS2023-507880-20-00Eurofins Optimed72
招募中
1 期
A phase I of TG6050 in the treatment of patients with metastatic lung canceron-small cell lung cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code: 10059515Term: Non-small cell lung cancer metastatic Class: 100000004864CTIS2024-513093-22-00Transgene36
进行中（未招募）
1 期
A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced TumorsAdvanced Malignant TumorsMedDRA version: 21.0Level: LLTClassification code: 10048683Term: Advanced cancer Class: 10029104CTIS2023-508280-69-00Bristol Myers Squibb International Corporation112